社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
shanshan88
IP属地：未知
+关注
帖子 · 28
帖子 · 28
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
shanshan88
shanshan88
·
2021-12-23
Thanks
Crocs to Buy Shoe Brand Heydude for $2.5 Billion to Boost Growth<blockquote>Crocs 将以 25 亿美元收购鞋履品牌 Heydude 以促进增长</blockquote>
(Bloomberg) -- Crocs Inc. agreed to buy casual-shoe brand Heydude for $2.5 billion, bolstering its f
Crocs to Buy Shoe Brand Heydude for $2.5 Billion to Boost Growth<blockquote>Crocs 将以 25 亿美元收购鞋履品牌 Heydude 以促进增长</blockquote>
看
2,894
回复
评论
点赞
1
编组 21备份 2
分享
举报
shanshan88
shanshan88
·
2021-11-08
Like pls
FDA Approves Eton's Formulated Topiramate For Seizure, Migraine Treatment<blockquote>FDA 批准 Eton 配制的托吡酯用于治疗癫痫、偏头痛</blockquote>
Eton Pharmaceuticals Inc and Azurity Pharmaceuticals Inc have announced that the FDA has approved Ep
FDA Approves Eton's Formulated Topiramate For Seizure, Migraine Treatment<blockquote>FDA 批准 Eton 配制的托吡酯用于治疗癫痫、偏头痛</blockquote>
看
2,340
回复
评论
点赞
1
编组 21备份 2
分享
举报
shanshan88
shanshan88
·
2021-11-06
Like pls
非常抱歉，此主贴已删除
看
2,741
回复
1
点赞
2
编组 21备份 2
分享
举报
shanshan88
shanshan88
·
2021-09-27
Like pls
非常抱歉，此主贴已删除
看
4,096
回复
1
点赞
1
编组 21备份 2
分享
举报
shanshan88
shanshan88
·
2021-09-27
Like pls
非常抱歉，此主贴已删除
看
2,507
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
shanshan88
shanshan88
·
2021-07-04
立刻
非常抱歉，此主贴已删除
看
2,367
回复
评论
点赞
1
编组 21备份 2
分享
举报
shanshan88
shanshan88
·
2021-05-29
Like
非常抱歉，此主贴已删除
看
2,203
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
shanshan88
shanshan88
·
2021-05-28
Like
非常抱歉，此主贴已删除
看
2,349
回复
1
点赞
2
编组 21备份 2
分享
举报
shanshan88
shanshan88
·
2021-05-28
Like
非常抱歉，此主贴已删除
看
2,554
回复
评论
点赞
1
编组 21备份 2
分享
举报
shanshan88
shanshan88
·
2021-05-22
Comment n like
非常抱歉，此主贴已删除
看
3,300
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3577599976368524","uuid":"3577599976368524","gmtCreate":1614505952934,"gmtModify":1614509444122,"name":"shanshan88","pinyin":"shanshan88","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":507,"tweetSize":28,"questionSize":0,"limitLevel":999,"accountStatus":2,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.08.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":698058112,"gmtCreate":1640267707374,"gmtModify":1640267882397,"author":{"id":"3577599976368524","authorId":"3577599976368524","name":"shanshan88","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577599976368524","idStr":"3577599976368524"},"themes":[],"title":"","htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698058112","repostId":"1197097469","repostType":4,"repost":{"id":"1197097469","kind":"news","pubTimestamp":1640265594,"share":"https://www.laohunote.com/m/news/1197097469?lang=zh_CN&edition=full","pubTime":"2021-12-23 21:19","market":"us","language":"en","title":"Crocs to Buy Shoe Brand Heydude for $2.5 Billion to Boost Growth<blockquote>Crocs 将以 25 亿美元收购鞋履品牌 Heydude 以促进增长</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1197097469","media":"Bloomberg","summary":"(Bloomberg) -- Crocs Inc. agreed to buy casual-shoe brand Heydude for $2.5 billion, bolstering its f","content":"<p><div> (Bloomberg) -- Crocs Inc. agreed to buy casual-shoe brand Heydude for $2.5 billion, bolstering its fast-growing business of offbeat footwear. The purchase will be funded by $2.05 billion in cash and $...</p><p><blockquote><div>（彭博社）——Crocs Inc. 同意以 25 亿美元收购休闲鞋品牌 Heydude，以增强其快速增长的另类鞋类业务。此次收购将由20.5亿美元的现金和美元提供资金……</div></blockquote></p><p> <a href=\"https://finance.yahoo.com/news/crocs-buy-shoe-brand-heydude-123248968.html\">网页链接</a> </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/crocs-buy-shoe-brand-heydude-123248968.html\">网页连接</a></blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Crocs to Buy Shoe Brand Heydude for $2.5 Billion to Boost Growth<blockquote>Crocs 将以 25 亿美元收购鞋履品牌 Heydude 以促进增长</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCrocs to Buy Shoe Brand Heydude for $2.5 Billion to Boost Growth<blockquote>Crocs 将以 25 亿美元收购鞋履品牌 Heydude 以促进增长</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Bloomberg</strong><span class=\"h-time small\">2021-12-23 21:19</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> (Bloomberg) -- Crocs Inc. agreed to buy casual-shoe brand Heydude for $2.5 billion, bolstering its fast-growing business of offbeat footwear. The purchase will be funded by $2.05 billion in cash and $...</p><p><blockquote><div>（彭博社）——Crocs Inc. 同意以 25 亿美元收购休闲鞋品牌 Heydude，以增强其快速增长的另类鞋类业务。此次收购将由20.5亿美元的现金和美元提供资金……</div></blockquote></p><p> <a href=\"https://finance.yahoo.com/news/crocs-buy-shoe-brand-heydude-123248968.html\">网页链接</a> </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/crocs-buy-shoe-brand-heydude-123248968.html\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/crocs-buy-shoe-brand-heydude-123248968.html\">Bloomberg</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CROX":"卡骆驰"},"source_url":"https://finance.yahoo.com/news/crocs-buy-shoe-brand-heydude-123248968.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197097469","content_text":"(Bloomberg) -- Crocs Inc. agreed to buy casual-shoe brand Heydude for $2.5 billion, bolstering its fast-growing business of offbeat footwear.\nThe purchase will be funded by $2.05 billion in cash and $450 million in Crocs shares issued to Heydude founder Alessandro Rosano, according to a statement Thursday. Crocs said it expects the deal to immediately add to its sales growth and earnings, while the combined operations will generate “significant” free cash flow.\nThe agreement underscores the rapid expansion of Crocs’ business as its once-derided foam clogs catch on with a hip Gen Z crowd. Crocs has said it expects revenue growth of as much as 65% this year. Heydude, which will operate as a stand-alone division, makes lightweight, casual shoes and sandals for men, women and children.\nCrocs shares fell 3.5% as of 7:17 a.m. before regular trading in New York. The stock soared 123% this year through Wednesday’s close.\nThe deal for closely held Heydude is expected to close in the first quarter. Crocs expects to fund the cash component with a $2 billion term loan B facility and borrow $50 million under its existing senior revolving credit facility.\nCiti is financial adviser to Crocs, while Perkins Coie LLP and Bird & Bird provide legal counsel. LVC Asia Pacific Ltd. is Heydude’s financial adviser, with Chiomenti, Deacons, Cozen O’Connor, Sullivan & Cromwell and Croon Law Group LLC serving as legal counsel.","news_type":1,"symbols_score_info":{"CROX":0.9}},"isVote":1,"tweetType":1,"viewCount":2894,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844055971,"gmtCreate":1636379888297,"gmtModify":1636380382936,"author":{"id":"3577599976368524","authorId":"3577599976368524","name":"shanshan88","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577599976368524","idStr":"3577599976368524"},"themes":[],"title":"","htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844055971","repostId":"1156155834","repostType":4,"repost":{"id":"1156155834","kind":"news","pubTimestamp":1636379472,"share":"https://www.laohunote.com/m/news/1156155834?lang=zh_CN&edition=full","pubTime":"2021-11-08 21:51","market":"us","language":"en","title":"FDA Approves Eton's Formulated Topiramate For Seizure, Migraine Treatment<blockquote>FDA 批准 Eton 配制的托吡酯用于治疗癫痫、偏头痛</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1156155834","media":"Benzinga","summary":"Eton Pharmaceuticals Inc and Azurity Pharmaceuticals Inc have announced that the FDA has approved Ep","content":"<p><div> Eton Pharmaceuticals Inc and Azurity Pharmaceuticals Inc have announced that the FDA has approved Eprontia (topiramate) oral solution, 25mg/mL. Eprontia has been approved as a monotherapy for partial-...</p><p><blockquote><div>Eton Pharmaceuticals Inc.和Azurity Pharmaceuticals Inc.宣布FDA已批准Eprontia（托吡酯）口服溶液，25mg/mL。Eprontia已被批准作为部分-……</div></blockquote></p><p> <a href=\"https://www.benzinga.com/general/biotech/21/11/23950419/fda-approves-etons-formulated-topiramate-for-seizure-migraine-treatment\">网页链接</a> </div> </p><p><blockquote><a href=\"https://www.benzinga.com/general/biotech/21/11/23950419/fda-approves-etons-formulated-topiramate-for-seizure-migraine-treatment\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA Approves Eton's Formulated Topiramate For Seizure, Migraine Treatment<blockquote>FDA 批准 Eton 配制的托吡酯用于治疗癫痫、偏头痛</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA Approves Eton's Formulated Topiramate For Seizure, Migraine Treatment<blockquote>FDA 批准 Eton 配制的托吡酯用于治疗癫痫、偏头痛</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-11-08 21:51</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Eton Pharmaceuticals Inc and Azurity Pharmaceuticals Inc have announced that the FDA has approved Eprontia (topiramate) oral solution, 25mg/mL. Eprontia has been approved as a monotherapy for partial-...</p><p><blockquote><div>Eton Pharmaceuticals Inc.和Azurity Pharmaceuticals Inc.宣布FDA已批准Eprontia（托吡酯）口服溶液，25mg/mL。Eprontia已被批准作为部分-……</div></blockquote></p><p> <a href=\"https://www.benzinga.com/general/biotech/21/11/23950419/fda-approves-etons-formulated-topiramate-for-seizure-migraine-treatment\">网页链接</a> </div> </p><p><blockquote><a href=\"https://www.benzinga.com/general/biotech/21/11/23950419/fda-approves-etons-formulated-topiramate-for-seizure-migraine-treatment\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/general/biotech/21/11/23950419/fda-approves-etons-formulated-topiramate-for-seizure-migraine-treatment\">Benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETON":"Eton Pharmaceuticals, Inc."},"source_url":"https://www.benzinga.com/general/biotech/21/11/23950419/fda-approves-etons-formulated-topiramate-for-seizure-migraine-treatment","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156155834","content_text":"Eton Pharmaceuticals Inc and Azurity Pharmaceuticals Inc have announced that the FDA has approved Eprontia (topiramate) oral solution, 25mg/mL.\nEprontia has been approved as a monotherapy for partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older.\nThe drug has also been approved as adjunctive therapy for partial-onset seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older; and as a preventive treatment of migraine in patients 12 years of age and older.\nEprontia is the first oral liquid formulation of topiramate to be approved by the FDA.\nAzurity will be responsible for commercializing the product, and it anticipates product availability by the end of 2021.\nEton will receive a $5 million milestone payment upon Eprontia's commercial launch, a royalty on net sales, and potential commercial milestones.\nPrice Action: ETON shares are down 3.66% at $6.06 during the premarket session on the last check Monday.","news_type":1,"symbols_score_info":{"ETON":0.9}},"isVote":1,"tweetType":1,"viewCount":2340,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842679165,"gmtCreate":1636175305571,"gmtModify":1636176750956,"author":{"id":"3577599976368524","authorId":"3577599976368524","name":"shanshan88","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577599976368524","idStr":"3577599976368524"},"themes":[],"title":"","htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/842679165","repostId":"1173813098","repostType":4,"isVote":1,"tweetType":1,"viewCount":2741,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866129027,"gmtCreate":1632749033169,"gmtModify":1632798138441,"author":{"id":"3577599976368524","authorId":"3577599976368524","name":"shanshan88","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577599976368524","idStr":"3577599976368524"},"themes":[],"title":"","htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/866129027","repostId":"2170264082","repostType":4,"isVote":1,"tweetType":1,"viewCount":4096,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866120784,"gmtCreate":1632749017548,"gmtModify":1632798138563,"author":{"id":"3577599976368524","authorId":"3577599976368524","name":"shanshan88","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577599976368524","idStr":"3577599976368524"},"themes":[],"title":"","htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/866120784","repostId":"2170264082","repostType":4,"isVote":1,"tweetType":1,"viewCount":2507,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":155682446,"gmtCreate":1625412330485,"gmtModify":1631891812724,"author":{"id":"3577599976368524","authorId":"3577599976368524","name":"shanshan88","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577599976368524","idStr":"3577599976368524"},"themes":[],"title":"","htmlText":"立刻","listText":"立刻","text":"立刻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/155682446","repostId":"1160702483","repostType":4,"isVote":1,"tweetType":1,"viewCount":2367,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":137364548,"gmtCreate":1622301837484,"gmtModify":1631891812730,"author":{"id":"3577599976368524","authorId":"3577599976368524","name":"shanshan88","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577599976368524","idStr":"3577599976368524"},"themes":[],"title":"","htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/137364548","repostId":"2138948877","repostType":4,"isVote":1,"tweetType":1,"viewCount":2203,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":134072236,"gmtCreate":1622196586925,"gmtModify":1631891812732,"author":{"id":"3577599976368524","authorId":"3577599976368524","name":"shanshan88","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577599976368524","idStr":"3577599976368524"},"themes":[],"title":"","htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/134072236","repostId":"2138109723","repostType":4,"isVote":1,"tweetType":1,"viewCount":2349,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":134072317,"gmtCreate":1622196555239,"gmtModify":1631891812735,"author":{"id":"3577599976368524","authorId":"3577599976368524","name":"shanshan88","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577599976368524","idStr":"3577599976368524"},"themes":[],"title":"","htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/134072317","repostId":"2138109757","repostType":4,"isVote":1,"tweetType":1,"viewCount":2554,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":133043769,"gmtCreate":1621675025651,"gmtModify":1631891812738,"author":{"id":"3577599976368524","authorId":"3577599976368524","name":"shanshan88","avatar":"https://static.tigerbbs.com/f1ad40f03dfd5bc695854371a0ca9c29","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577599976368524","idStr":"3577599976368524"},"themes":[],"title":"","htmlText":"Comment n like","listText":"Comment n like","text":"Comment n like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/133043769","repostId":"2137907575","repostType":4,"isVote":1,"tweetType":1,"viewCount":3300,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}